Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
SOPHiA GENETICS is a rapidly growing data-driven medicine company at the forefront of the genomic and clinical data analysis revolution. Operating within the healthcare and biotechnology sector, they provide a Software-as-a-Service (SaaS) platform, SOPHiA DDM, that leverages artificial intelligence and machine learning to analyze complex genomic and clinical data. Their key business focus lies in democratizing access to this data, enabling faster and more accurate diagnoses, accelerating drug discovery, and improving patient outcomes. With a strong presence in both Europe and the US, and increasing global reach, SOPHiA GENETICS is positioned as a leading player in empowering healthcare providers and pharmaceutical companies with actionable insights derived from genomic information, helping to advance precision medicine worldwide.
Department | HeadCount |
---|---|
Administrative | 8 |
Consulting | 10 |
Service | 20 |
Design | 4 |
Education | 0 |
The department distribution within SOPHiA GENETICS reveals a clear emphasis on technological innovation and market-driven scalability. The prominence of the 'Technical' (89 employees) and 'Research' (53 employees) departments underscores the company's commitment to continuously developing and refining its AI-powered SOPHiA DDM platform. This focus aligns directly with their SaaS business model, where ongoing technological advancements are crucial for maintaining a competitive edge. A substantial 'Operations' team (31 employees) highlights the importance of efficient service delivery and the ability to scale their platform to meet growing customer demand. The 'Sales' department (37 employees) reflects a proactive approach to expanding their market share and driving revenue growth, vital for a company in a competitive, evolving market. The significant number of employees in 'Other Department' (88 employees) potentially signifies specialized roles related to unique aspects of their technology or specific project implementations with clients. The core support functions such as 'Marketing' (10 employees), 'HR' (11 employees), 'Finance' (14 employees), 'Consulting' (10 employees) and 'Product' (14 employees) although smaller, are critical for supporting the company's overall operations and strategic growth initiatives. The smaller 'Medical' team (3 employees) likely reflects a strategic focus on software and data analysis rather than direct patient care, potentially relying on external medical partnerships and experts to validate and apply their insights. While the 'Customer Service' department (20 employees) is adequate, a robust and continuously improving customer support structure will be critical for long-term customer satisfaction and retention, especially as the platform's user base expands. Overall, SOPHiA GENETICS' workforce structure is strongly aligned with its SaaS-based genomic analysis business model, prioritizing technological advancement, operational efficiency, and strategic market expansion.
Total: 419 employees
SOPHiA GENETICS operates as a globally distributed organization with a significant concentration of its workforce in Europe and a growing presence in North America. The strong presence in Switzerland (189 employees) and France (80 employees) suggests that these locations serve as key operational and potentially research and development hubs. The substantial number of employees in the United States (72 employees) indicates a strategic focus on the North American market, a critical region for growth in the healthcare and biotechnology sectors. The presence in several other European countries (Germany, Italy, Spain, UK, etc.) further solidifies its strong foothold in the European market. Their expanding presence in Latin America (Brazil, Colombia, Mexico, Chile) and Asia (India, Taiwan, Singapore, Malaysia, Indonesia) shows a commitment to global expansion and serving a diverse range of healthcare systems and patient populations. The smaller employee counts in regions like Australia/New Zealand (3 employees), Eastern Asia (1 employee), and Southern Asia (4 employees) likely represent initial market entry efforts or strategic partnerships in these areas, potentially indicating future growth opportunities. This global footprint aligns perfectly with their business model, which benefits from access to diverse genomic datasets and healthcare systems, ultimately enhancing the power and applicability of their AI-powered platform. By establishing a widespread global presence, SOPHiA GENETICS aims to position itself as a leading player in the global data-driven medicine landscape, able to provide valuable insights to healthcare providers and pharmaceutical companies worldwide.
Get alerts when hiring spikes or teams shift focus
Track changes vs. competitors
Spot warm GTM signals early